$KIDS

Squadron Capital LLC sold $7.8M of KIDS

Squadron Capital LLC sold 336,831 shares of ORTHOPEDIATRICS CORP (KIDS) at an average of $23.04 ($23.04–$23.10, $7.76M total) across 2 trades over 2026-08-28 to 2026-09-01. Filed jointly with Squadron Capital Holdings LLC (10% owner).

Original reporting
SEC EDGAR · Squadron Capital LLC, Squadron Capital Holdings LLC
Published Sep 1, 2026, 10:48 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 1, 2026, 11:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KIDS
Neutral
medium confidence
Mentioned
$KIDS
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KIDSNeutralLow
01

Why it matters

The disclosed sale provides fresh data on insider holdings, useful for short‑term positioning.

02

Market read

The filing offers a new data point for traders monitoring insider activity in KIDS.

03

What to watch

Squadron Capital's remaining 6.5M shares still represent a large influence; the sale may be a routine liquidity move.

Relevance 6/10Novelty 6/10Timing: filing released after market close on Sep 1, 2026

Background

Form 4 filings disclose insider transactions; they are primary sources for ownership changes.

Company-level read

Ticker impact

$KIDSNeutralMedium confidence
Context

Squadron Capital LLC sold 336,831 shares of Orthopedics Corp (KIDS) for $7.76M in an open‑market transaction filed on Sep 1, 2026.

Expected impact

Potential modest downward pressure as a 10% owner exits a portion of its position.

Evidence & confidence

A $7.8M sale by a 10% owner signals possible portfolio rebalancing; market reaction likely limited given the remaining large stake.

Market effects

Minimal impact on the orthopedics device sector; insider sales are routine.

No significant regional effect.

Limited to investors tracking KIDS.

Counterpoint

The sale could be a signal of upcoming negative news, suggesting a short opportunity.

Key entities

  • Orthopedics Corp

    Public medical device company trading under ticker KIDS.

  • Squadron Capital LLC

    10% owner of Orthopedics Corp filing the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KIDSMed

OrthoPediatrics Corp. Q2 2026 Earnings Call Summary

OrthoPediatrics reported Q2 2026 progress toward a “financial inflection point,” citing record adjusted EBITDA margins near 10% and a shift toward positive free cash flow. Trauma and Deformity revenue grew 26% on implant share gains and early 3P Hip deployments. Management expects positive free cash flow in H2 2026 and FCF break-even or better for full-year 2026, with conservative timing assumptions for capital placements and international orders.